Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron and ESA Combination in Renal Transplant
NCT05719376Phase 4Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Feb 2023
- Primary completion
- May 2026
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric derisomaltose, Epoetin alfa RB in anemia, sponsored by Yonsei University. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
ferric derisomaltoseEpoetin alfa RB
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05719376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05719376.